996.0000 -22.05 (-2.17%)
NSE Jun 02, 2025 15:31 PM
Volume: 70,556
 

996.00
-2.17%
BOB Capital Markets Ltd.
Revenue/EBITDA/ PAT grew 6.7%/8% and 19% above our estimates. EBITDA margin reported 20bps above estimates of 15.4% in 4QFY25
Number of FII/FPI investors decreased from 213 to 198 in Mar 2025 qtr
More from Alembic Pharmaceuticals Ltd.
Recommended